Molecular assessment of p53 abnormalities at the invasive front of oral squamous cell carcinomas
暂无分享,去创建一个
K. Tory | J. Piffkó | A. Bankfalvi | U. Joos | K. Schmid | L. Füzesi | D. Öfner | M. Bryne | F. Kusch
[1] W. Knepel. Transcriptional Control of Pancreatic Islet Hormones Gene Expression , 2009, Experimental and clinical endocrinology.
[2] Dowell Sp,et al. THE P53 TUMOUR SUPPRESSOR GENE AND TUMOUR PROGNOSIS : IS THERE A RELATIONSHIP ? , 1995 .
[3] H. Dosaka-akita,et al. Simultaneous use of the PCR-SSCP method and immunohistochemistry for increasing the detection efficacy of p53 abnormalities in human lung cancer. , 1995, American journal of clinical pathology.
[4] J. Piffkó,et al. Expression of p53 protein in oral squamous cell carcinomas and adjacent non-tumorous mucosa of the floor of the mouth: an archival immunohistochemical study using wet autoclave pretreatment for antigen retrieval. , 1995, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[5] G. Wilson,et al. p53 status of head and neck cancer: relation to biological characteristics and outcome of radiotherapy. , 1995, British Journal of Cancer.
[6] K. Sasaki,et al. The significance of PCNA and p53 protein in some oral tumors. , 1995, International journal of oral and maxillofacial surgery.
[7] J. Piffkó,et al. Immunohistochemical detection of p53 protein in archival tissues from squamous cell carcinomas of the oral cavity using wet autoclave antigen retrieval , 1995, The Journal of pathology.
[8] J. Armand,et al. High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions. , 1995, Oncogene.
[9] Y. Yoshihama,et al. Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas. , 1995, Anticancer research.
[10] A. Bankfalvi,et al. Wet autoclave pretreatment for antigen retrieval in diagnostic immunohistochemistry , 1994, The Journal of pathology.
[11] C. Harris,et al. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. , 1994, Cancer research.
[12] R. Elledge,et al. p53 protein accumulation detected by five different antibodies: relationship to prognosis and heat shock protein 70 in breast cancer. , 1994, Cancer research.
[13] J. Gluckman,et al. Prognostic significance of p53 protein accumulation in early stage T1 oral cavity cancer. , 1994, European journal of cancer. Part B, Oral oncology.
[14] D. Meek. Post-translational modification of p53. , 1994, Seminars in cancer biology.
[15] T. Soussi,et al. Multifactorial analysis of p53 alteration in human cancer: A review , 1994, International journal of cancer.
[16] Yao-Tseng Chen,et al. Frameshift and nonsense p53 mutations in squamous-cell carcinoma of head and neck - non-reactivity with 3 anti-p53 monoclonal-antibodies. , 1994, International journal of oncology.
[17] C. R. Teixeira,et al. Proliferating cell nuclear antigen expression at the invasive tumor margin predicts malignant potential of colorectal carcinomas , 1994, Cancer.
[18] B. Vojtesek,et al. Problems with p53 immunohistochemical staining: the effect of fixation and variation in the methods of evaluation. , 1994, British Journal of Cancer.
[19] P. Kelehan,et al. Variations in immunohistochemical detection of p53 protein overexpression in cervical carcinomas with different antibodies and methods of detection , 1994, The Journal of pathology.
[20] F. Bosch,et al. Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumors. , 1993, Cancer research.
[21] S. Schantz. Carcinogenesis, markers, staging, and prognosis of head and neck cancer. , 1993, Current opinion in oncology.
[22] D. Ruiter,et al. Increased expression of cytokeratins 8, 18 and vimentin in the invasion front of mucosal squamous cell carcinoma , 1993, The Journal of pathology.
[23] W. Hong,et al. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. , 1993, Cancer research.
[24] S. Lippman,et al. Head and Neck Cancer , 1993, Cancer Treatment and Research.
[25] N. Johnson,et al. Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions. , 1992, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[26] A. Levine,et al. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation , 1992, Cell.
[27] R. Callahan. p53 mutations, another breast cancer prognostic factor. , 1992, Journal of the National Cancer Institute.
[28] J. Minna,et al. Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. , 1992, Oncogene.
[29] Magne Bryne,et al. Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value , 1992, The Journal of pathology.
[30] B. Vogelstein,et al. p53 mutations in human cancers. , 1991, Science.
[31] T. Sekiya,et al. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. , 1989, Genomics.
[32] H. Miller. Japanese Pharmaceutical Biotechnology: Perception vs. Reality , 1989, Bio/Technology.
[33] C. Merril,et al. Silver staining of DNA in polyacrylamide gels: Linearity and effect of fragment size , 1982 .
[34] A. Levine,et al. Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells , 1982, Cell.
[35] D. Slaughter,et al. “Field cancerization” in oral stratified squamous epithelium. Clinical implications of multicentric origin , 1953, Cancer.
[36] L. Kowalski,et al. Presentation Risk factors for second cancers of the upper respiratory and digestive systems: A case-control study , 1991 .
[37] R. Allen,et al. Polymerase chain reaction amplification products separated on rehydratable polyacrylamide gels and stained with silver. , 1989, BioTechniques.
[38] H. Torloni,et al. Histological typing of oral and oropharyngeal tumours , 1971 .